Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 5
1989 8
1990 13
1991 17
1992 10
1993 13
1994 16
1995 16
1996 16
1997 8
1998 23
1999 24
2000 10
2001 19
2002 19
2003 18
2004 18
2005 19
2006 23
2007 23
2008 38
2009 29
2010 20
2011 34
2012 32
2013 26
2014 28
2015 21
2016 18
2017 40
2018 31
2019 4
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

600 results
Results by year
Filters applied: . Clear all
Page 1
Endoscopic Management of Primary Sclerosing Cholangitis.
Barkin JA, et al. Ann Hepatol 2017 - Review. PMID 29055922 Free article.
Primary sclerosing cholangitis (PSC) remains a rare but potentially devastating chronic, cholestatic liver disease. PSC causes obstruction of intra- and/or extra-hepatic bile ducts by inflammation and fibrosis, leading to biliary obstruction, cirrhosis and portal hypertension with all associated sequelae. ...Fourt and finally, Dosing of antibiotics is critical to prevent peri-procedural cholangitis. The aim of this review article is to explore endoscopic tools and techniques for the diagnosis and management of PSC and provide a practical approach for clinicians....
Primary sclerosing cholangitis (PSC) remains a rare but potentially devastating chronic, cholestatic liver disease. PSC causes …
[Secondary sclerosing cholangitis in critically ill patients].
Peña-Pérez CA and Díaz Ponce-Medrano JA. Cir Cir 2018 - Review. PMID 29681633 Spanish.
Primary sclerosing cholangitis (PSC) is a rare idiopathic condition with immunopathogenic mechanisms where there is chronic progressive destruction of the biliary tree. Secondary sclerosing cholangitis (SSC) is clinically comparable to PSC, but is caused by specific processes which directly damage the biliary tree; examples include recurrent pancreatitis, bile duct malignancy, congenital bile duct abnormalities. ...
Primary sclerosing cholangitis (PSC) is a rare idiopathic condition with immunopathogenic mechanisms where there is chronic pr …
Endoscopic management of primary sclerosing cholangitis.
Tabibian JH and Baron TH. Expert Rev Gastroenterol Hepatol 2018 - Review. PMID 29883229
Primary sclerosing cholangitis (PSC) is a rare but clinically important cholestatic liver disease. Histopathologically and cholangiographically, PSC is characterized by intra- and/or extra-hepatic bile duct inflammation and fibro-obliteration, which ultimately leads to biliary cirrhosis and related sequelae, including development of hepatobiliary and colorectal carcinomata. ...
Primary sclerosing cholangitis (PSC) is a rare but clinically important cholestatic liver disease. Histopathologically and cho …
Restorative Surgery in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis Following a Colectomy.
Nordenvall C, et al. Inflamm Bowel Dis 2018. PMID 29462381
BACKGROUND: Studies on surgical procedures in patients with concomitant primary sclerosing cholangitis (PSC) and ulcerative colitis (UC) have mainly been restricted to single centers. ...The impact of PSC on the risk of colectomy, the chance of restorative surgery, and risk of failure (presence of a stoma) following restorative surgery were estimated. ...
BACKGROUND: Studies on surgical procedures in patients with concomitant primary sclerosing cholangitis (PSC) and ulcerative co …
Liver Transplant in Patients with Primary Sclerosing Cholangitis: Long-Term Experience of a Single Center.
Astarcioglu I, et al. Exp Clin Transplant 2018 - Clinical Trial. PMID 30060730 Free article.
OBJECTIVES: Primary sclerosing cholangitis is a chronic inflammatory disease of the intrahepatic and extrahepatic bile ducts. ...Primary sclerosing cholangitis recurrence developed in 2 patients (18.1%). Three patients (27.2%) died during the follow-up period. ...
OBJECTIVES: Primary sclerosing cholangitis is a chronic inflammatory disease of the intrahepatic and extrahepatic bile ducts. …
The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
Deneau MR, et al. Hepatology 2017 - Clinical Trial. PMID 28390159
There are limited data on the natural history of primary sclerosing cholangitis (PSC) in children. We aimed to describe the disease characteristics and long-term outcomes of pediatric PSC. ...
There are limited data on the natural history of primary sclerosing cholangitis (PSC) in children. We aimed to describe the di …
IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma.
Lin J, et al. Scand J Gastroenterol 2015. PMID 25635498
AIMS: IgG4-related sclerosing cholangitis in extrahepatic bile ducts in the absence of autoimmune pancreatitis (AIP) is rare and is poorly studied. Herein, we present the clinicopathological features of four cases of IgG4-related sclerosing cholangitis. METHODS AND RESULTS: The clinicopathological features of IgG4-related sclerosing cholangitis were compared with those of IgG4-related sclerosing cholangitis with AIP (n = 7), extrahepatic cholangiocarcinoma (n = 29), primary sclerosing cholangitis (n = 40), and secondary sclerosing cholangitis (n = 12). ...
AIMS: IgG4-related sclerosing cholangitis in extrahepatic bile ducts in the absence of autoimmune pancreatitis (AIP) is rare a …
No Superiority of Stents vs Balloon Dilatation for Dominant Strictures in Patients With Primary Sclerosing Cholangitis.
Ponsioen CY, et al. Gastroenterology 2018 - Clinical Trial. PMID 29803836
BACKGROUND & AIMS: Dominant strictures occur in approximately 50% of patients with primary sclerosing cholangitis (PSC). Short-term stents have been reported to produce longer resolution of dominant strictures than single-balloon dilatation. ...There were 17 treatment-related SAEs: post-ERCP pancreatitis in 9 patients and bacterial cholangitis in 4 patients. SAEs occurred in 15 patients in the stent group (45%) and in only 2 patients in the balloon dilatation group (6.7%) (odds ratio, 11.7; 95% confidence interval, 2.4-57.2; P = .001). ...
BACKGROUND & AIMS: Dominant strictures occur in approximately 50% of patients with primary sclerosing cholangitis (PSC). S …
Management and follow-up of gallbladder polyps : Joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery - European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE).
Wiles R, et al. Eur Radiol 2017. PMID 28185005 Free PMC article.
To address this a joint guideline was created by the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery - European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE). ...
To address this a joint guideline was created by the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Associat …
600 results
Jump to page
Feedback